Skip to content

H.B. Fuller

US · FUL #2581 by market cap Listed 1970
49.91 -0.72 -1.42%
Live - 5344 symbols - heartbeat 307s ago · 2026-10-08 07:40
Pre-market 49.91 0.00%
After-hours 49.91 0.00%
Market cap
2.69B
P/B
1.24
EPS
2.75
Reader sentiment Are you bullish or bearish on FUL?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Below fair value
56.48 fair value ≈ 67.80 79.11
  • Implied fair-value range of 56.48-79.11, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -26.4% below the average-multiple fair value of 67.80.

Valuation each multiple against its own 5-year range

P/B ratio 1.26 Cheap vs history 1st percentile
5-year average 2.08 · #16 of 56 in Specialty Chemicals
P/E ratio 14.10 Cheap vs history 1st percentile
5-year average 24.65 · forward 12.89 · #5 of 32 in Specialty Chemicals
P/S ratio 0.77 Cheap vs history 1st percentile
5-year average 1.03 · forward 0.72 · #15 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
H.B. Fuller (FUL) 2.69B 13.90 1.24 1.92%
Linde (LIN) 223.11B 31.22 5.71 1.28%
Ecolab (ECL) 77.96B 37.33 7.75 1.02%
Sherwin-Williams (SHW) 76.47B 29.06 19.84 1.01%
Air Products & Chemicals (APD) 61.93B -1,324.38 4.46 2.59%
PPG Industries (PPG) 23.36B 15.03 2.77 2.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value69.26 Economic moatNone UncertaintyHigh

Trading 38.8% below Morningstar's fair value estimate.

Fair value

H.B. Fuller Co is assigned a 5-star quantitative star rating, reflecting our opinion that this share class offers a compelling opportunity for investors. The stock currently trades at a 27% discount to our quantitative fair value estimate of $69.26 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's valuation metrics increase our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 80.2% sits in the top 40% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 4.1, for example, sits in the bottom 30% globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:40:18 · For reference only, not investment advice and not tailored to your situation.